We are delighted to invite you to the very first ‘Monsoon Rheumatology Summit’ to be held at Kochi on the 21st and 22nd of July, 2018.

  • Call Us+91 965 6084 284

Scientific Programme

Scleroderma

Section 1
Scleroderma: the path travelled
Section 2
INTERSTITIAL LUNG DISEASE
  • Interpretation of the Curves - PFT and DLCO
  • Utility of HRCT in SSc - ILD
  • How to choose right patient and right drugs in SSC - ILD
Section 3
Pulmonary Hypertension
  • How and when to screen PH ?
  • How to interpret Echo and Right heart catheterization ?
  • Management of CTD - PAH
Section 4
VASCULAR DISEASE
  • Microvascular disease : Raynaud’s and digital gangrene: Approach and management
  • Macrovascular disease : How common is it ? How to screen ? How to treat ?
Section 5
PATHOGENESIS OF FIBROSIS AND EMERGING ANTI - FIBROTICS IN SCLERODERMA
Section 6
SKIN DISEASE
  • Role, intensity and titration of immunosuppression in isolated skin disease
  • Cutaneous ulcers in scleroderma - over view and case based discussion
Section 7
GASTROINTESTINAL INVOLVEMENT
  • Management of esophageal dysmotility
  • Hepatic disease in systemic sclerosis : evaluation and management
Section 8
NEWER THERAPIES
  • Haematopoietic stem cell transplantation for scleroderma
  • Role of biologics in patients with systemic sclerosis
  • End stage lung disease – Role of transplantation and end of life care
Section 9
CHALLENGING CASES WITH MANAGEMENT DILEMMAS WITH PANEL DISCUSSION

Spondyloarthritis

Section 1
Spondyloarthritis criteria and beyond
Section 2
Imaging in axial SpA
  • Role of conventional X-ray in axial SpA : How relevant is it?
  • Practical session on interpretation of X-rays
  • Role of MRI in diagnosis & management of axial SpA : update
  • Case studies emphasising importance and fallacies of MRI
  • Radiological mimics of SpA
Section 3
Pathogenesis of axial SpA : Current concepts
Section 4
MANAGEMENT OF axial SpA
  • Role of NSAIDs and conventional DMARDs in the management of axial SpA
  • Anti TNF in AS – current concepts
  • Anti IL-17 therapy in axial SpA
  • LTBI : diagnosis and management
  • Similars vs Originators : Does it really matter?
  • Treat to target : Are we there in axial SpA?
Section 5
Debate : What should be the first agent in axial SpA? anti TNF vs anti IL17
Section 6
Miscellaneous
  • Transition of ERA to axial SpA : What a rheumatologist should know ?
  • Extra axial manifestations : over view & case based discussion
  • Osteoporosis : How to assess and when to treat ?
  • Fibromyalgia in axial SpA : challenges